![]() ![]() This industry currently has a Zacks Industry Rank of 98, which puts it in the top 39% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. is currently a Zacks Rank #3 (Hold).The Medical - Drugs industry is part of the Medical sector. Within the past 30 days, our consensus EPS projection has moved 4.1% lower. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). We developed the Zacks Rank to capitalize on this phenomenon. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. These revisions typically reflect the latest short-term business trends, which can change frequently. The company is expected to report EPS of -$0.29, up 40.82% from the prior-year quarter.Any recent changes to analyst estimates for Acer Therapeutics Inc. as it approaches its next earnings report date. This has lagged the Medical sector's gain of 2.17% and the S&P 500's gain of 2.28% in that time.Wall Street will be looking for positivity from Acer Therapeutics Inc. Elsewhere, the Dow gained 1.26%, while the tech-heavy Nasdaq added 5.21%.Prior to today's trading, shares of the company had lost 63.42% over the past month. The stock lagged the S&P 500's daily gain of 1.44%. (ACER) closed the most recent trading day at $0.76, moving +1.13% from the previous trading session.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |